Literature DB >> 18434569

A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension.

Julie E Goodwin1, Junhui Zhang, David S Geller.   

Abstract

Although glucocorticoid (GC)-induced hypertension has commonly been attributed to promiscuous activation of the mineralocorticoid receptor by cortisol, thereby promoting excess reabsorption of sodium and water, numerous lines of evidence indicate that this is not the only or perhaps even the primary mechanism. GC induce a number of effects on vascular smooth muscle (VSM) in vitro that may be pertinent to hypertension, but their contribution in vivo is unknown. To address this question, a mouse model with a tissue-specific knockout (KO) of the GC receptor in the VSM was created and characterized. Similar to control mice, KO mice exhibited normal baseline BP and, interestingly, showed normal circadian variation in BP. When dexamethasone was administered, however, the acute hypertensive response was markedly attenuated in KO mice, and there was a trend toward a decreased chronic hypertensive response. These data suggest that the GC receptor in VSM plays a critical role in the acute hypertensive response to GC in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434569      PMCID: PMC2440298          DOI: 10.1681/ASN.2007080911

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Glucocorticoid treatment and cardiovascular disease.

Authors:  M K C Ng; D S Celermajer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 2.  Glucocorticoids and vascular reactivity.

Authors:  Shumei Yang; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2004-01       Impact factor: 2.719

Review 3.  Glucocorticoids and the kidney.

Authors:  George J Mangos; Judith A Whitworth; Paula M Williamson; John J Kelly
Journal:  Nephrology (Carlton)       Date:  2003-12       Impact factor: 2.506

4.  Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.

Authors:  Elke De Wachter; Anne Malfroot; Iris De Schutter; Jesse Vanbesien; Jean De Schepper
Journal:  J Cyst Fibros       Date:  2003-06       Impact factor: 5.482

5.  Mineralocorticoid effects in the kidney: correlation between alphaENaC, GILZ, and Sgk-1 mRNA expression and urinary excretion of Na+ and K+.

Authors:  Olivier G Muller; Rimma G Parnova; Gabriel Centeno; Bernard C Rossier; Dmitri Firsov; Jean-Daniel Horisberger
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

6.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.

Authors:  Rita Holtwick; Michael Gotthardt; Boris Skryabin; Martin Steinmetz; Regine Potthast; Bernd Zetsche; Robert E Hammer; Joachim Herz; Michaela Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

7.  Effects of midazolam on the contraction and relaxation of segments of thoracic aorta stripped of endothelium and stimulated by adrenaline--experimental study in rabbits.

Authors:  Antônio Aires Ferreira Rodrigues Borges; Otoni Moreira Gomes
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

8.  Comparison of the effects of 'glucocorticoid' and 'mineralocortocoid' infusions on blood pressure in sheep.

Authors:  J A Whitworth; J P Coghlan; D A Denton; W F Graham; T J Humphery; B A Scoggins
Journal:  Clin Exp Hypertens       Date:  1979       Impact factor: 1.749

Review 9.  Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.

Authors:  Felix J Frey; A Odermatt; Brigitte M Frey
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-07       Impact factor: 2.894

10.  Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.

Authors:  T Zelinka; B Strauch; L Pecen; J Widimský
Journal:  J Hum Hypertens       Date:  2004-02       Impact factor: 3.012

View more
  28 in total

Review 1.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Authors:  Graziela Z Kalil; William G Haynes
Journal:  Hypertens Res       Date:  2011-11-03       Impact factor: 3.872

Review 2.  Vascular inward rectifier K+ channels as external K+ sensors in the control of cerebral blood flow.

Authors:  Thomas A Longden; Mark T Nelson
Journal:  Microcirculation       Date:  2015-04       Impact factor: 2.628

3.  Metabolic syndrome after a liver transplantation in an Asian population.

Authors:  Hwee Leong Tan; Kieron B L Lim; Shridhar Ganpathi Iyer; Stephen K Y Chang; Krishnakumar Madhavan; Alfred W C Kow
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

Review 4.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

5.  Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David Gonzalez; Sebastian Albinsson; David S Geller
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

6.  Endothelial glucocorticoid receptor suppresses atherogenesis--brief report.

Authors:  Julie E Goodwin; Xinbo Zhang; Noemi Rotllan; Yan Feng; Han Zhou; Carlos Fernández-Hernando; Jun Yu; William C Sessa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-19       Impact factor: 8.311

7.  Stress-induced glucocorticoid signaling remodels neurovascular coupling through impairment of cerebrovascular inwardly rectifying K+ channel function.

Authors:  Thomas A Longden; Fabrice Dabertrand; David C Hill-Eubanks; Sayamwong E Hammack; Mark T Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-07       Impact factor: 11.205

8.  The glucocorticoid receptor in the distal nephron is not necessary for the development or maintenance of dexamethasone-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; Heino Velazquez; David S Geller
Journal:  Biochem Biophys Res Commun       Date:  2010-02-24       Impact factor: 3.575

Review 9.  Update on Treatment of Hypertension After Renal Transplantation.

Authors:  Christos Chatzikyrkou; Roland E Schmieder; Mario Schiffer
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

10.  Endothelial glucocorticoid receptor is required for protection against sepsis.

Authors:  Julie E Goodwin; Yan Feng; Heino Velazquez; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.